Add Yahoo as a preferred source to see more of our stories on Google. With a little help, your immune cells can be potent tumor killers. Steve Gschmeissner/Science Photo Library via Getty Images The ...

MRNA COVID-19 vaccination and cancer risk are examined in a case report and review that explores a reported temporal ...

Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

The EMA approved Moderna's mRNA COVID-19 and flu vaccine, but US political battles and funding cuts threaten the future of mRNA vaccine innovation. Talha Burki reports.

A group of experts that advises the US Centers for Disease Control and Prevention on its vaccine recommendations has ...

Among adolescents and young adults, cTnI levels remain within normal ranges after mRNA-1273 vaccination, with no evidence of increased myocardial injury.

Invivyd, Inc. is a Sell as recent trial expansion signals weaker-than-hoped efficacy and introduces further delays for ...

Sanofi today announces it has become the market authorization holder in Canada for Nuvaxovid, a non-mRNA protein-based ...

mRNA COVID-19 vaccines in early pregnancy do not increase the risk of major congenital malformations in infants. The study used data from the Mother-Child EPI-MERES Register, covering over 99% of the ...

One example of this potential comes from studies on glioblastoma, an aggressive brain tumor with few effective treatments.

(THE CONVERSATION) The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a ...